Publications by authors named "Guy Toner"

Claim this Profile
P
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.
Ciara Conduit, Jeremy Lewin, Andrew Weickhardt, James Lynam, Shirley Wong, Guy Toner

JCO Oncol Pract· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad

Cancer Imaging· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Elizabeth A Connolly, Andrew Weickhardt, Peter Grimison, Rebecca Asher, Gillian Z Heller, Guy Toner

BJU Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary function testing for the early detection of drug-induced lung disease: a systematic review in adults treated with drugs associated with pulmonary toxicity.
Allan Bui, Sangjin Han, Marliese Alexander, Guy Toner, Lou Irving

Intern Med J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.
Hayley S Whitford, Pawel Kalinowski, Adrian Schembri, Peter Grimison, Martin Stockler, Guy C Toner

Support Care Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.
Nicola J Lawrence, Howard Chan, Guy Toner, Martin R Stockler, Andrew Martin

BMC Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors.
Allan Ben Smith, Claudia Rutherford, Phyllis Butow, Ian Olver, Tim Luckett, Guy Toner

Psychooncology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.
Allan Ben Smith, Phyllis Butow, Ian Olver, Tim Luckett, Peter Grimison, Guy C Toner

J Cancer Surviv· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Growing Teratoma Syndrome With Spuriously Elevated α-Fetoprotein.
Adam Pendlebury, Danny Rischin, Kerryn Ireland-Jenkin, Guy C Toner, Peter Grant

J Clin Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncology.
Shomik Sengupta, Peter Grimison, Dickon Hayne, Scott Williams, Suzanne Chambers, Guy Toner

BJU Int· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular cancer: Optimal management of stage I seminoma in 2015.
Guy C Toner

Nat Rev Urol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study.
Allan Ben Smith, Madeleine King, Phyllis Butow, Tim Luckett, Peter Grimison, Guy C Toner

Psychooncology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance is the preferred approach to clinical stage I testicular cancer.
Craig R Nichols, Bruce Roth, Peter Albers, Lawrence H Einhorn, Richard Foster, Guy Toner

J Clin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer.
Peter Grimison, Baerin Houghton, Mark Chatfield, Guy C Toner, Ian D Davis

BJU Int· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies.
Andrew M Scott, Paul L Mitchell, Graeme O'Keefe, Timothy Saunder, Rodney J Hicks, Guy C Toner

EJNMMI Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, Denise K Reinke, Klaus-Peter Kuenkele, Guy C Toner

J Clin Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Andrew J Stephenson, Armen G Aprikian, Timothy D Gilligan, Jan Oldenburg, Tom Powles, Guy C Toner

Urology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
Peter S Grimison, Martin R Stockler, Damien B Thomson, Ian N Olver, Vernon J Harvey, Guy C Toner

J Natl Cancer Inst· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.
Carmel Pezaro, Mark A Rosenthal, Howard Gurney, Ian D Davis, Craig Underhill, Guy C Toner

Am J Clin Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood.
Kenneth K Khamly, Vicky J Thursfield, Michael Fay, Jayesh Desai, Guy C Toner

Int J Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist.
Anthony J White, Andre LaGerche, Guy C Toner, Robert J Whitbourn

Int J Cardiol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor.
Guy C Toner

J Clin Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late relapsing stage I nonseminoma.
Carmel J Pezaro, Girish Mallesara, Guy C Toner

J Clin Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET for sarcomas other than gastrointestinal stromal tumors.
Guy C Toner, Rodney J Hicks

Oncologist· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.
Sarah-Jane Dawson, Nelly Marmy Conus, Guy C Toner, Jeanette M Raleigh, Rodney J Hicks

Anticancer Drugs· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis